Cargando…

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model

PD-L1 expression is associated with poor prognosis, although this relationship is unclear in bone marrow-derived haematologic malignancies, including multiple myeloma. We aimed to determine whether PD-L1 expression could predict the prognosis of newly diagnosed multiple myeloma (NDMM). We evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Byung-Hyun, Park, Yong, Kim, Ji Hye, Kang, Ka-Won, Lee, Seung Jin, Kim, Seok Jin, Kim, Byung Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387472/ https://www.ncbi.nlm.nih.gov/pubmed/32724129 http://dx.doi.org/10.1038/s41598-020-69616-5

Ejemplares similares

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization
por: Kang, Ka-Won, et al.
Publicado: (2020)

Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)

PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2022)

Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

Bone Marrow Plasma Cell Assessment before Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2014)

Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
por: Lee, Se Ryeon, et al.
Publicado: (2010)

Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
por: Eom, Ki-Seong, et al.
Publicado: (2014)

Persistent Anemia in a Patient with Diffuse Large B Cell Lymphoma: Pure Red Cell Aplasia Associated with Latent Epstein-Barr Virus Infection in Bone Marrow
por: Sung, Hwa Jung, et al.
Publicado: (2007)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation
por: Moon, Kyoung Yong, et al.
Publicado: (2016)

The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma
por: Kang, Ka-Won, et al.
Publicado: (2021)

Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas
por: Choi, Euno, et al.
Publicado: (2020)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
por: Lee, Se Ryeon, et al.
Publicado: (2019)

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium
por: Lee, Seung-Jin, et al.
Publicado: (2020)

Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
por: Kim, Seon Young, et al.
Publicado: (2013)

Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
por: Yousef, S, et al.
Publicado: (2015)

A Novel Anti-PD-L1 Antibody Exhibits Antitumor Effects on Multiple Myeloma in Murine Models via Antibody-Dependent Cellular Cytotoxicity
por: Ahn, Jae-Hee, et al.
Publicado: (2021)

Effect of platelet-rich plasma on the degenerative rotator cuff tendinopathy according to the compositions
por: Kim, Sang Jun, et al.
Publicado: (2019)

Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis
por: Lee, Ji Young, et al.
Publicado: (2021)

Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma
por: Shim, Hyoeun, et al.
Publicado: (2014)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Survival Nomogram for Curatively Resected Korean Gastric Cancer Patients: Multicenter Retrospective Analysis with External Validation
por: Eom, Bang Wool, et al.
Publicado: (2015)

Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation
por: Lee, Byung-Hyun, et al.
Publicado: (2023)

Development of a novel nomogram for predicting ongoing pregnancy after in vitro fertilization and embryo transfer
por: Kim, Seul Ki, et al.
Publicado: (2018)

The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
por: Min, Chang-Ki, et al.
Publicado: (2013)

Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
por: Hwang, In Hye, et al.
Publicado: (2011)

Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma
por: Lee, Min Young, et al.
Publicado: (2021)

Prognostic implications of PD-L1 expression in patients with angiosarcoma
por: Lee, Jii Bum, et al.
Publicado: (2021)

Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple Myeloma
por: Song, Ik-Chan, et al.
Publicado: (2015)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

The Relationship between Renal Function and Bone Marrow Density in Healthy Korean Women
por: Park, Byung Kyu, et al.
Publicado: (2017)

Giant anal condyloma (giant condyloma acuminatum of anus) after allogeneic bone marrow transplantation associated with human papillomavirus: a case report
por: Hyun, Jin-Soo, et al.
Publicado: (2015)

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
por: Park, Yong-Jin, et al.
Publicado: (2021)

The Effect of Platelet Rich Plasma from Bone Marrow Aspirate with Added Bone Morphogenetic Protein-2 on the Achilles Tendon-Bone Junction in Rabbits
por: Kim, Hak Jun, et al.
Publicado: (2011)

Bone Marrow Gouty Tophi With Plasma Cell Myeloma
por: Bang, Hae In, et al.
Publicado: (2020)

Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma
por: Choi, Hayoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_58pvqbv2ul7ncrivdf1vdiue7n